Microbot Medical Inc (MBOT) Stock Price, Quote & News

Company Profile

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides No...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 781 875 3605

Website: microbotmedical.com

Address:

175 Derby Street, Bld. 27, Hingham, United States

Nocluewhatimdoin_ Apr. 28 at 6:39 PM

$MBOT Another conference next month too

1 · Reply

GladysFoster Apr. 28 at 3:46 PM

$MBOT this is retail being shaken out, plain and simple. What's changed, nothing. They have a great product and it's just getting started, people expect high singles or even low double digits within weeks of launch.. If you wanted 100% you should have got in at one in the many many moths before FDA approval. Next 100% + is going to take a few quarters. This will hit the 2 mark I would think and possibly a tad lower. Just my thoughts.

0 · Reply

NoItWasntMe Apr. 28 at 2:55 PM

$MBOT IMO after all the years of effort and (sadly) dilution, and while waiting for sales and pricing updates over the next many months, they have a couple immediate issues: - Their vague optimism re their only manufacturing partner who is at extreme risk, imo. At the very least they should elaborate that they are actively engaged in discussions with other manufactures in the US and elsewhere. - Vagueness re distribution partners. It doesn’t seem to be Stryker any more (if it ever was) at least not explicitly mentioned in recent filings (unless I missed that). In fact, Stryker recently partnered with Siemens Heathineers to develop robotics for neurovascular targets. Not the end of the world by any means, but vagueness is not doing the stock any favors. Which is fine, lots of patience to accumulate. Anyhow

1 · Reply

StStephen72 Apr. 28 at 2:07 PM

$MBOT IDK if this is going to pay off this year or not BUT I swear no more BioTech for me. Suck at pick anything Bio. Can't wait for this to pop soni can get out. SMH. Pete

1 · Reply

Bdin42 Apr. 28 at 1:53 PM

$MBOT time for some news to turn this in the other direction!!

0 · Reply

Eddypgil Apr. 28 at 1:27 PM

$MBOT $2 won’t hold

0 · Reply

DragonAlgo Apr. 28 at 10:17 AM

🐉 $MBOT CALL — DragonAlgo® Signal Contract: MBOT CALL Expiry: 2026-05-15 | Strike: $2.00 | Type: CALL Option Plan (premium): Entry: $0.30 Stop: $0.22 TP1: $0.39 TP2: $0.51 TP3: $0.72 Momentum tape remains active. 🔗 https://dragonalgo.com

0 · Reply

MoonTargets Apr. 27 at 10:41 PM

$RILY $SERV $MBOT $RUM trending

0 · Reply

FlyingTargets Apr. 27 at 7:51 PM

$HIVE $PATH $MBOT $SMMT %(

0 · Reply

Eddypgil Apr. 27 at 6:46 PM

$MBOT should hit $4.50 after fda approval

2 · Reply

Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®

Apr 14, 2026, 2:30 PM EDT - 14 days ago

Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference

Apr 13, 2026, 8:30 AM EDT - 15 days ago

Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting

Mar 26, 2026, 8:30 AM EDT - 4 weeks ago

Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®'s LIBERTY® Endovascular Robotic System

Mar 24, 2026, 8:30 AM EDT - 5 weeks ago

Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal

Mar 17, 2026, 8:40 AM EDT - 6 weeks ago

Microbot Medical® to Participate at the 38th Annual Roth Conference

Mar 10, 2026, 8:30 AM EDT - 7 weeks ago

Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time

Mar 4, 2026, 8:30 AM EST - 7 weeks ago

Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation

Mar 3, 2026, 9:00 AM EST - 2 months ago

Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event

Feb 24, 2026, 1:48 PM EST - 2 months ago

Tampa General Hospital Adopts Small-Cap Microbot Medical's Robotic System

Feb 24, 2026, 8:30 AM EST - 2 months ago

Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System

Feb 19, 2026, 8:30 AM EST - 2 months ago

Microbot Medical®'s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference

Feb 12, 2026, 8:30 AM EST - 2 months ago

Microbot Medical®'s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference

Feb 5, 2026, 8:30 AM EST - 2 months ago

Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption

Jan 12, 2026, 8:30 AM EST - 3 months ago

Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones

Nov 26, 2025, 8:30 AM EST - 5 months ago

Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System

Nov 5, 2025, 8:30 AM EST - 6 months ago

Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.

Oct 16, 2025, 8:30 AM EDT - 6 months ago

Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting

Oct 14, 2025, 8:30 AM EDT - 7 months ago

Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System

Oct 7, 2025, 8:00 AM EDT - 7 months ago

Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Oct 1, 2025, 9:00 AM EDT - 7 months ago

Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio

Sep 23, 2025, 8:30 AM EDT - 7 months ago

Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System

Sep 16, 2025, 3:37 PM EDT - 8 months ago

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Sep 15, 2025, 8:00 AM EDT - 8 months ago

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds

Sep 9, 2025, 8:28 AM EDT - 8 months ago

REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

Sep 8, 2025, 8:28 AM EDT - 8 months ago

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

Aug 20, 2025, 8:30 AM EDT - 8 months ago

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

Aug 5, 2025, 8:30 AM EDT - 9 months ago

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

Jul 22, 2025, 8:30 AM EDT - 10 months ago

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

Jul 8, 2025, 8:30 AM EDT - 10 months ago

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting

Jun 30, 2025, 8:30 AM EDT - 10 months ago

Microbot Medical® Added to the Russell Microcap® Index

Jun 17, 2025, 8:30 AM EDT - 11 months ago

Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China

Jun 9, 2025, 8:30 AM EDT - 11 months ago

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System

Jun 5, 2025, 8:30 AM EDT - 11 months ago

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index

Apr 23, 2025, 8:30 AM EDT - 1 year ago

Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers

Apr 9, 2025, 8:30 AM EDT - 1 year ago

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

Apr 1, 2025, 8:30 AM EDT - 1 year ago

REMINDER: Microbot Medical Announces Data from the Company's ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

Mar 4, 2025, 8:30 AM EST - 1 year ago

Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System

Feb 25, 2025, 8:30 AM EST - 1 year ago

Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting

Feb 11, 2025, 6:15 PM EST - 1 year ago

Microbot Medical Closes $13 Million Registered Direct Offering

Feb 10, 2025, 8:00 AM EST - 1 year ago

Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jan 10, 2025, 10:25 AM EST - 1 year ago

Microbot Medical Closes $8.6 Million Registered Direct Offering

Jan 7, 2025, 4:15 PM EST - 1 year ago

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

Dec 30, 2024, 8:30 AM EST - 1 year ago

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

Dec 10, 2024, 10:18 AM EST - 1 year ago

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

Oct 15, 2024, 8:38 AM EDT - 1 year ago

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

Sep 30, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

Sep 17, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

Aug 22, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

Aug 13, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

Nocluewhatimdoin_ Apr. 28 at 6:39 PM

$MBOT Another conference next month too

1 · Reply

GladysFoster Apr. 28 at 3:46 PM

0 · Reply

NoItWasntMe Apr. 28 at 2:55 PM

1 · Reply

StStephen72 Apr. 28 at 2:07 PM

$MBOT IDK if this is going to pay off this year or not BUT I swear no more BioTech for me. Suck at pick anything Bio. Can't wait for this to pop soni can get out. SMH. Pete

1 · Reply

Bdin42 Apr. 28 at 1:53 PM

$MBOT time for some news to turn this in the other direction!!

0 · Reply

Eddypgil Apr. 28 at 1:27 PM

$MBOT $2 won’t hold

0 · Reply

DragonAlgo Apr. 28 at 10:17 AM

0 · Reply

MoonTargets Apr. 27 at 10:41 PM

$RILY $SERV $MBOT $RUM trending

0 · Reply

FlyingTargets Apr. 27 at 7:51 PM

$HIVE $PATH $MBOT $SMMT %(

0 · Reply

Eddypgil Apr. 27 at 6:46 PM

$MBOT should hit $4.50 after fda approval

2 · Reply

ImCrazy Apr. 27 at 5:27 PM

$MBOT consecutive price levels are classic ATM behavior

1 · Reply

blirp Apr. 27 at 1:55 PM

$MBOT

0 · Reply

SaySomethingNice Apr. 27 at 1:00 PM

$GAME DYOR.. $AIXI $KALA $MBOT $IXHL

0 · Reply

Djmorri Apr. 27 at 12:18 PM

$MBOT. Too many explosive growth story Companies out there showing explosive revenue to wait for this one. Gonna be a couple more years of dilution pollution for sure

0 · Reply

AnthonyTradingWithJesus Apr. 27 at 5:05 AM

$MBOT $MOBX $MBAI $WING $WYNN Stocktwits did a good job with this interview I think.

0 · Reply

NoItWasntMe Apr. 26 at 5:08 AM

$MBOT The more I research this company, the more intrigued I am by its potential. However, they have one serious risk beyond potential market uptake: they seem to only have one manufacturer, in Tiberius Israel, which is seemingly at very high risk. I know they issued a PR re everything being fine, BUT IMO they should have taken steps much earlier to secure at least one other manufacturer. They currently have zero manufacturing resilience as far as I can tell. If anyone can indicate otherwise, I would love to see evidence of that. Wording in their PRs seems to indicate that they’ve been stocking up both internally and through distributors, but I don’t see anything regarding a second manufacturer. I believe it takes 6 to 12 months to qualify a new manufacturer, so it is not a quick lift. Stocking up can be a nice buffer in case something terrible happens, but they really need a secondary manufacturer at the very least. All imo as always.

0 · Reply

Eddypgil Apr. 26 at 1:43 AM

$MBOT very disappointing

0 · Reply

MorganHoratio Apr. 25 at 7:15 PM

The top stocks of each sector in the market IMO: Space & Connectivity 📡 - $ASTS > all AI Infrastructure: 🤖 - $NBIS - $IREN - $CIFR Spot on picks! $ASTS is dominating with its D2C satellite moat. For AI Infra, $NBIS is a key sleeper in silicon photonics—crucial for breaking power bottlenecks. $IREN & $CIFR are perfectly positioned for the HPC pivot. $MBOT is facing warrant pressure, but a 10-15% dip could be the ultimate entry for patient capital. Are you betting on Space Tech or the next wave of AI compute? Let’s debate below!

0 · Reply

wallstjam Apr. 24 at 3:52 PM

$MBOT it doesn't really matter with a pre revenue company like this, but if you look at the 6m chart you can see a big reverse head and shoulders and then more recently a small head and shoulders forming. Kinda fun.

1 · Reply

D541 Apr. 24 at 3:37 PM

$MBOT the only one holding up these days

0 · Reply

FLNY Apr. 24 at 3:27 PM

$MBOT

0 · Reply

Bdin42 Apr. 24 at 12:22 PM

$MBOT

0 · Reply

Market Cap	147.75M
Revenue (ttm)	0.00
Net Income (ttm)	-13.14M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	1,014,067
Avg Vol	1,917,254
Day's Range	N/A - N/A
Shares Out	67.16M
Stochastic %K	13%
Beta	1.19
Analysts	Strong Sell
Price Target	$7.50